Although there are now clear associations between ulcer disease and in
fection with Helicobacter pylori or use of nonsteroidal anti-inflammat
ory drugs (NSAIDs), it remains unclear how these factors affect the ab
ility of the gastroduodenal mucosa to resist injury tie, mucosal defen
se). Progress has been made in understanding the factors that regulate
mucus and bicarbonate secretion in the upper gastrointestinal tract,
and the influence of antiulcer drugs leg, lansoprazole, omeprazole) on
these factors. The discovery of two isoforms of the enzyme responsibl
e for prostaglandin synthesis has resulted in a reappraisal of the rol
e of this class of mediators in mucosal defense, and an evaluation of
the theory that selective inhibitors of the inducible form of this enz
yme will be ''GI safe.'' The most active area of research in mucosal d
efense over the past year was concerned with factors influencing mucos
al repair. A number of growth factors have been identified as playing
key roles in the ulcer healing process. Moreover, the role of these fa
ctors in improving the quality of ulcer healing has been carefully exa
mined.